clinical trial · NCT05747430
SteRilizing Eye SoLution to ImprovE Patient ComFort (RELIEF)
iRenix Medical, Inc.·phase2·completed·n = 155
Retinal DiseaseIRX-101Providone-Iodine
brief summary
This is a randomized, double-masked study to evaluate the tolerability and safety of IRX-101 versus 5% povidone-iodine (PI) in subjects receiving intravitreal anti-VEGF injections. The study will be conducted in up to 15 centers in the United States (US).
started
Feb 22, 2023
primary completion
Mar 6, 2025
completion
Mar 31, 2026
last updated
Apr 3, 2026
official title
Randomized, Controlled, Double-Masked Study to Evaluate the Efficacy of IRX-101 in Reducing Post-Intravitreal Injection Pain and Corneal Epitheliopathy
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol